(4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone

C145H143ClF3N25O15 — CID 160615413

IUPAC(4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone
SMILESCOc1nccnc1C(=O)N1CCn2nc(OCc3ccccc3)cc2C1.Cc1cc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)ccc1Cl.Cc1ccc(C(=O)N2CCCn3nc(OCc4ccccc4)cc3C2)cc1.Cc1ccc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)cc1.Cc1cccc(C(=O)N2CCCn3nc(OCc4ccccc4)cc3C2)c1.Cc1ncc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)cn1.O=C(c1ccccc1C(F)(F)F)N1CCn2nc(OCc3ccccc3)cc2C1
InChIInChI=1S/2C22H23N3O2.C21H20ClN3O2.C21H18F3N3O2.C21H21N3O2.C19H19N5O3.C19H19N5O2/c1-17-7-5-10-19(13-17)22(26)24-11-6-12-25-20(15-24)14-21(23-25)27-16-18-8-3-2-4-9-18;1-17-8-10-19(11-9-17)22(26)24-12-5-13-25-20(15-24)14-21(23-25)27-16-18-6-3-2-4-7-18;1-15-11-17(7-8-19(15)22)21(26)24-9-10-25-18(13-24)12-20(23-25)27-14-16-5-3-2-4-6-16;22-21(23,24)18-9-5-4-8-17(18)20(28)26-10-11-27-16(13-26)12-19(25-27)29-14-15-6-2-1-3-7-15;1-16-7-9-18(10-8-16)21(25)23-11-12-24-19(14-23)13-20(22-24)26-15-17-5-3-2-4-6-17;1-26-18-17(20-7-8-21-18)19(25)23-9-10-24-15(12-23)11-16(22-24)27-13-14-5-3-2-4-6-14;1-14-20-10-16(11-21-14)19(25)23-7-8-24-17(12-23)9-18(22-24)26-13-15-5-3-2-4-6-15/h2-5,7-10,13-14H,6,11-12,15-16H2,1H3;2-4,6-11,14H,5,12-13,15-16H2,1H3;2-8,11-12H,9-10,13-14H2,1H3;1-9,12H,10-11,13-14H2;2-10,13H,11-12,14-15H2,1H3;2-8,11H,9-10,12-13H2,1H3;2-6,9-11H,7-8,12-13H2,1H3
InChIKeyRGAHVSWZADSZQD-UHFFFAOYSA-N
MW2568.35 g/mol
LogP23.41
Rot. Bonds29

About (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone

(4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone (PubChem CID 160615413) has the molecular formula C145H143ClF3N25O15 and a molecular weight of 2568.35 g/mol. Its IUPAC name is (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone.

Molecular Properties

Compound Name(4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone
PubChem CID160615413
Molecular FormulaC145H143ClF3N25O15
Molecular Weight2568.35 g/mol
Exact Mass2566.08
IUPAC Name(4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone
SMILESCOc1nccnc1C(=O)N1CCn2nc(OCc3ccccc3)cc2C1.Cc1cc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)ccc1Cl.Cc1ccc(C(=O)N2CCCn3nc(OCc4ccccc4)cc3C2)cc1.Cc1ccc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)cc1.Cc1cccc(C(=O)N2CCCn3nc(OCc4ccccc4)cc3C2)c1.Cc1ncc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)cn1.O=C(c1ccccc1C(F)(F)F)N1CCn2nc(OCc3ccccc3)cc2C1
InChIInChI=1S/2C22H23N3O2.C21H20ClN3O2.C21H18F3N3O2.C21H21N3O2.C19H19N5O3.C19H19N5O2/c1-17-7-5-10-19(13-17)22(26)24-11-6-12-25-20(15-24)14-21(23-25)27-16-18-8-3-2-4-9-18;1-17-8-10-19(11-9-17)22(26)24-12-5-13-25-20(15-24)14-21(23-25)27-16-18-6-3-2-4-7-18;1-15-11-17(7-8-19(15)22)21(26)24-9-10-25-18(13-24)12-20(23-25)27-14-16-5-3-2-4-6-16;22-21(23,24)18-9-5-4-8-17(18)20(28)26-10-11-27-16(13-26)12-19(25-27)29-14-15-6-2-1-3-7-15;1-16-7-9-18(10-8-16)21(25)23-11-12-24-19(14-23)13-20(22-24)26-15-17-5-3-2-4-6-17;1-26-18-17(20-7-8-21-18)19(25)23-9-10-24-15(12-23)11-16(22-24)27-13-14-5-3-2-4-6-14;1-14-20-10-16(11-21-14)19(25)23-7-8-24-17(12-23)9-18(22-24)26-13-15-5-3-2-4-6-15/h2-5,7-10,13-14H,6,11-12,15-16H2,1H3;2-4,6-11,14H,5,12-13,15-16H2,1H3;2-8,11-12H,9-10,13-14H2,1H3;1-9,12H,10-11,13-14H2;2-10,13H,11-12,14-15H2,1H3;2-8,11H,9-10,12-13H2,1H3;2-6,9-11H,7-8,12-13H2,1H3
InChIKeyRGAHVSWZADSZQD-UHFFFAOYSA-N
XLogP23.41
TPSA392.31 Ų
H-Bond Donors
H-Bond Acceptors33
Rotatable Bonds29
Heavy Atoms189
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002568.35
LogP ≤ 523.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1033

Analyze (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone?
The IUPAC name of (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone (CID 160615413) is (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone.
What is the SMILES notation for (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone?
The canonical SMILES for (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone is COc1nccnc1C(=O)N1CCn2nc(OCc3ccccc3)cc2C1.Cc1cc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)ccc1Cl.Cc1ccc(C(=O)N2CCCn3nc(OCc4ccccc4)cc3C2)cc1.Cc1ccc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)cc1.Cc1cccc(C(=O)N2CCCn3nc(OCc4ccccc4)cc3C2)c1.Cc1ncc(C(=O)N2CCn3nc(OCc4ccccc4)cc3C2)cn1.O=C(c1ccccc1C(F)(F)F)N1CCn2nc(OCc3ccccc3)cc2C1.
What is the InChIKey of (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone?
The InChIKey is RGAHVSWZADSZQD-UHFFFAOYSA-N. The full InChI is InChI=1S/2C22H23N3O2.C21H20ClN3O2.C21H18F3N3O2.C21H21N3O2.C19H19N5O3.C19H19N5O2/c1-17-7-5-10-19(13-17)22(26)24-11-6-12-25-20(15-24)14-21(23-25)27-16-18-8-3-2-4-9-18;1-17-8-10-19(11-9-17)22(26)24-12-5-13-25-20(15-24)14-21(23-25)27-16-18-6-3-2-4-7-18;1-15-11-17(7-8-19(15)22)21(26)24-9-10-25-18(13-24)12-20(23-25)27-14-16-5-3-2-4-6-16;22-21(23,24)18-9-5-4-8-17(18)20(28)26-10-11-27-16(13-26)12-19(25-27)29-14-15-6-2-1-3-7-15;1-16-7-9-18(10-8-16)21(25)23-11-12-24-19(14-23)13-20(22-24)26-15-17-5-3-2-4-6-17;1-26-18-17(20-7-8-21-18)19(25)23-9-10-24-15(12-23)11-16(22-24)27-13-14-5-3-2-4-6-14;1-14-20-10-16(11-21-14)19(25)23-7-8-24-17(12-23)9-18(22-24)26-13-15-5-3-2-4-6-15/h2-5,7-10,13-14H,6,11-12,15-16H2,1H3;2-4,6-11,14H,5,12-13,15-16H2,1H3;2-8,11-12H,9-10,13-14H2,1H3;1-9,12H,10-11,13-14H2;2-10,13H,11-12,14-15H2,1H3;2-8,11H,9-10,12-13H2,1H3;2-6,9-11H,7-8,12-13H2,1H3.
What are the key properties of (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone?
(4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone has a molecular weight of 2568.35 g/mol, XLogP of 23.41, 29 rotatable bonds, 0 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for (4-chloro-3-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methoxypyrazin-2-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(3-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(4-methylphenyl)-(2-phenylmethoxy-4,6,7,8-tetrahydropyrazolo[1,5-a][1,4]diazepin-5-yl)methanone;(2-methylpyrimidin-5-yl)-(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)methanone;(2-phenylmethoxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazin-5-yl)-[2-(trifluoromethyl)phenyl]methanone is sourced from PubChem (CID 160615413), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).